Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,765,744
-
Share change
-
-8,995,359
-
Total reported value
-
$39,893,870
-
Put/Call ratio
-
4920%
-
Price per share
-
$0.93
-
Number of holders
-
99
-
Value change
-
-$10,764,807
-
Number of buys
-
44
-
Number of sells
-
61
Institutional Holders of ACORDA THERAPEUTICS INC - COM (ACOR) as of Q1 2020
As of 31 Mar 2020,
ACORDA THERAPEUTICS INC - COM (ACOR) was held by
99 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,765,744 shares.
The largest 10 holders included
BlackRock Inc., FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, ACADIAN ASSET MANAGEMENT LLC, Point72 Asset Management, L.P., Partner Fund Management, L.P., STATE STREET CORP, and Invesco Ltd..
This page lists
99
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.